Tech v Human Touch in Patient Care

Technology has been bringing about massive changes in many industries over the last few years and has brought about much innovation and success. But industries that involve the human element have sparked much debate.

Healthcare tops the list, it can be argued that where a machine can perform a given task, sometimes more efficiently than a human being, it also lacks the unique human ability to understand and meet the needs of a patient. An algorithm may suggest a logical solution, but a human expert in their field understands when to take a different approach.

In a speech made by the Deputy Prime Minister and Minister of Finance Mr Heng Swee Keat at the Singapore Health Quality Service Awards on 13 January 2020, he spoke about leveraging technology so healthcare professionals can focus on the most important part of their role – patient care.

“Another key to keeping our healthcare system sustainable is to leverage technology, to free up time for healthcare professionals to focus on patient care” said Deputy Prime Minister and Minister of Finance Mr Heng Swee Keat.

He said that Research and development in healthcare is a key priority of the governments Research, Innovation and Enterprise 2020 plan. It is also a key focus under the Healthcare Industry Transformation Map.

He mentioned one such example at Changi General Hospital where HOSPI the robot helps to deliver items from room to room. This frees up time for staff to focus on more meaningful aspects of their job, especially interacting with patients.

The Minister emphasised that no matter how advanced medical technology gets, genuine care for patients will always remain a critical part of the healthcare system. Although acknowledging the importance of technology in making the healthcare system more efficient and effective, he emphasised “There is no substitute for the human touch.”

Technology Enhancing Patient Care

Technology today is helping provide patients with a better level of care by providing doctors with faster access to health records, allowing doctors to view medical images on any platform and ensuring data is integrated and stored securely meaning doctors can focus on the human element of providing care to the patient.

PureStorage is one company that offers such solutions to the Healthcare industry such as: Medical Imaging to be available in real-time on any device, faster access to health information to assist with critical clinical decision making, Next-Gen Electronic Health Records, Data platforms for integrated care.

Pure healthcare solutions aim to drive productivity, enabling organisations to more efficiently share and use their data – and to make faster, better decisions based on real-time, data-driven intelligence.

Solving Healthcare Challenges with Technology and Measuring Success

In a recent OpenGov interview with Dr Ngiam Kee Yuan, Group Chief Technology Officer of the National University Health System (NUHS) Singapore solving healthcare challenges with technology was discussed.

Dr Ngiam Kee Yuan said “There are many challenges that healthcare systems face, but they can broadly be broken down into pre-hospital, intra-hospital and post-hospital phases. Solutions to pre-hospital problems involve the use of AI chatbots and health coaches to engage healthy individuals. Intra-hospital solutions revolving around AI machines which assists clinicians in their work. Post-hospital solutions focus on tracking patients’ compliance with medication and appointments.”

Dr Ngiam stressed the importance of measuring the effect of technology on clinical services and to continually adapt to the needs of end-users. Success is measured on how well a technology addresses the problem, using metrics such as improvement in clinical quality against costs.

Success Lies in the Convergence Between Digital Health and True Human Interaction

There is no doubt that technology can enhance the doctor-patient relationship and the level of care the patient will receive but true healthcare technology success lies in the merging of digital health and true human interaction, bringing together minds and machines to sharpen knowledge and insight to improve the delivery of care for patients, practitioners and providers.

Singapore: Magnetic Muscle Therapy Reversing Ageing Trends

Digital innovation empowers ageing individuals by promoting better health management, social engagement, cognitive stimulation, safety, and access to resources, ultimately improving their overall quality of life.

While ageing is frequently accompanied by a deterioration in functional mobility, loss of muscle strength, and an increase in body fat, this trend could be reversed thanks to a novel magnetic muscle therapy developed by researchers at the National University of Singapore (NUS).

Weekly exposure to very low levels of proprietary pulsed electromagnetic field (PEMF) using the BIXEPS device invented by NUS researchers in 2019 is associated with significant improvements in mobility and body composition after 12 weeks, particularly in older people, according to a recent community study conducted in Singapore involving 101 participants aged 38 to 91 years old. After three months of magnetic muscle therapy, participants reported reduced pain perception.

Associate Professor Alfredo Franco-Obregón, who led the research team and is a Principal Investigator with NUS iHealthtech and co-founder of QuantumTX, says that the BIXEPS device uses a specific magnetic signature to target the muscles in a user’s leg and create metabolic activity in the cells, just like when a person exercises.

Studies from the past showed that when magnetic muscle treatment was used on one leg after knee surgery, the whole body’s metabolism improved. This was mostly seen as changes in the blood lipid profiles. That is, the effect went beyond just the leg that was treated and led to changes throughout the whole body.

After eight weeks of treatment, 72% of individuals reported improved skeletal muscle maintenance along with reductions in total and visceral fats, with 85% of subjects reporting improvements in functional mobility after 12 weeks, most notably among the elderly.

These encouraging findings suggest that this PEMF-based technology could be a beneficial adjunct to traditional geriatric therapies aimed at lowering the prevalence of frailty and metabolic diseases in the elderly population.

Importantly, visceral fat is an inflammatory fat that has been linked to a variety of metabolic diseases, including diabetes. Previous research has found that people in Southeast Asia retain visceral fat more persistently than persons in other regions of the world, despite exercise.

As a result, people in Southeast Asia get diabetes at a lower BMI than persons of other ethnicities. This has created a significant challenge for the Southeast Asian health business. Researchers finally have a solution to this local healthcare dilemma in the form of magnetic field therapy.

Based on the promising findings of the community study, the team has collaborated with research groups in the United States and Hong Kong to perform randomised controlled clinical studies to further validate the advantages of frailty across various ageing groups.

Since 2022, the team has also begun a senior-focused study with 200 elders across four Singapore community care centres to assess how the technology can improve function and ease chronic problems. This research is projected to be completed in 2023.

Real-world pilot data from current community programmes have also shown promise of improved HbA1c control – the most common measure for diabetes progression – after beginning weekly BIXEPS sessions.

The research team is currently collaborating with the Singapore General Hospital to perform a clinical trial to evaluate further the therapeutic potential of PEMF-based therapies for diabetes progression management.

New Hi-Tech Lab Advanced Cellular Therapies Hong Kong

The Hong Kong Science and Technology Parks Corporation (HKSTP) and the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), have jointly announced the introduction of the HKU-HKSTP Collaborative Programme and the inauguration of the HKUMed Laboratory of Cellular Therapeutics.

The state-of-the-art Good Manufacturing Practice (GMP) laboratory serves the purpose of protecting public health and facilitating the advancement of advanced therapy products (ATPs). With this significant development, new avenues of research and the production of ATPs, such as stem cell therapy for cardiac diseases led by Professor Tse Hung-fat and CAR-T cell therapy for blood cancers led by Professor Eric Tse Wai-choi, are now made possible. The products manufactured in this facility will benefit a wide range of patients, and the acquired clinical experience will further drive the progress of innovative therapies.

The HKUMed GMP Lab has a primary objective of producing clinical-grade advanced therapy products (ATPs) as investigational medicinal products (IMPs) specifically for use in clinical trials. Additionally, it serves as an innovative training platform for scientists and clinicians, offering unique opportunities for skill development.

Notably, this facility holds the distinction of being Hong Kong’s first GMP multi-products establishment with provisional approval from the HKSAR Department of Health for an ATP manufacturing license. Moreover, it functions as a training centre aligned with the standards of the Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme (PIC/S), ensuring compliance with Good Manufacturing Practice (GMP) guidelines. The centre caters to the training needs of key personnel involved in ATP manufacturing, quality control, and quality assurance processes.

To establish Hong Kong as a prominent hub for the development of advanced therapy products (ATPs), two crucial factors are emphasised: talent training and international collaboration. The HKUMed GMP Lab has successfully implemented a joint training program with the Scottish National Blood Transfusion Service (SNBTS) and University College London (UCL), resulting in a skilled workforce capable of effectively operating the facility.

Additionally, HKU is actively engaged in the development of ATP translational training at both undergraduate and postgraduate levels, in collaboration with esteemed international partners such as UCL and Cell Therapies Pty Ltd in Melbourne.

This collaborative effort aims to equip students with the necessary knowledge and skills in gene and cell therapies. The establishment of the HKUMed GMP Lab not only provides unparalleled learning opportunities but also serves as a crucial bridge in transforming research discoveries made by HKUMed into tangible products that can benefit patients.

To facilitate the commercialisation of local research breakthroughs, the HKUMed GMP Lab will engage in collaborations with biotechnology companies to undertake Good Manufacturing Practice (GMP) projects and pilot trials. The focus will be on establishing clinical trials for CAR-T and stem cell therapies within the next five years, with the goal of benefiting not only cancer patients but also those with non-cancer conditions.

This progress sets the stage for future product development at the Jockey Club Centre for Clinical Innovation and Discovery, located at Grantham Hospital. The upcoming centre will feature a GMP laboratory for gene and cell therapy on a significantly larger scale, enabling the HKUMed GMP Lab to collaborate with pharmaceutical companies in the localised manufacturing of cellular products, particularly for CAR-T therapies. This concerted effort aims to accelerate the translation of innovative therapies into practical solutions that can positively impact patient care.

Dr Grace Lau, the Head of the Institute for Translational Research at HKSTP, emphasised the significance of the GMP facility in facilitating the translation of promising research from local universities and biotech companies into clinical applications. HKSTP is dedicated to solidifying Hong Kong’s position as a leading hub for biomedical technology in Asia. This commitment involves providing essential infrastructure, securing international recognition, attracting investments, and fostering strategic partnerships. The HKU-HKSTP Collaborative Programme plays a vital role in strengthening Hong Kong’s ecosystem for advanced therapy products (ATPs) and significantly enhancing the city’s global competitiveness in the research and commercialization of next-generation cell and gene therapies.

Professor Tse Hung-fat, the academic lead of the HKUMed Laboratory of Cellular Therapeutics, expressed confidence in HKU’s efforts to gather top industry talents and establish itself as a premier ATP training hub in Hong Kong and the Greater Bay Area.

Fuelling Digital Growth: Singapore’s Continuing ICT Investments

Singapore will spend about S$3.3 billion on information and communications technology (ICT) this year. This is on top of the money it has spent in previous years to improve its digital infrastructure and make services better for people, companies, and government workers.

Over the last five years, the government has spent about S$16 billion on ICT. In both FY 2021 and FY 2022, it was expected that S$3.8 billion would be spent on ICT. In the past, attempts to combine the demand for ICT services through bulk tenders and to update the back-end ICT infrastructure of the government through the cloud have saved money.

“Our ICT investments in the past five years have laid a firm foundation for the next bound of digital government,” said Kok Ping Soon, Chief Executive, GovTech.

He added that the Government will maintain a high level of ICT spending in 2023, as they continue to push ahead with the cloud strategy and find more ways to work closely with the industry through co-developed projects and bulk tenders. Providing opportunities for SMEs to take on government projects is also important, as SMEs form a key pillar of our Smart Nation efforts, he continued.

More than 30% (S$1 billion) of what the government plans to spend on ICT in FY 2023 will go towards developing apps for the Government Commercial Cloud (GCC).

Since the “Cloud First” Strategy was announced in October 2018, about 66% of qualified government systems have been moved to the Government Commercial Cloud (GCC). This makes it possible to reach the goal of 70% by the end of 2023.

In FY 2023, co-developed projects with industry are projected to be worth about 45% (S$1.49 billion) of all spending, up from 27% in FY 2022 and 20% in FY 2021.

Co-developed projects save time and money by using the SG Tech Stack and other government platforms for security compliance and interoperability, as well as reusing well-tested software components to build apps quickly.

Currently, 27 companies are qualified to work with the government on projects using the SG Tech Stack. When the S$0.62 billion Agile Co-Development and ICT Professional Services bulk tender is called in FY 2023, this list of providers will be updated.

In co-developed projects, engineers and developers from the government may oversee building one part while their peers from the private sector build another. This is different from the usual outsourced approach, in which a vendor builds the whole project based on what the government agency wants.

As a result of the Government’s planned ICT spending for FY 2023, a lot more projects will be given out through bulk bids. About 76%, or S$2.5 billion, of the planned spending will go to these projects. In FY 2022, only 27% of the spending went to these projects. By putting together all the requests for the same ICT goods and services, bulk tenders have helped public agencies save money, time, and effort.

This year, there are three important bulk contracts worth a total of S$1.85 billion: Enterprise Software-as-a-Service (SaaS), Hosting Support Services (HSS), and Personal Computers & Printer.

Small and medium-sized businesses (SMEs) still have a lot of chances, as nearly 80% of all procurement opportunities for FY 2023 will be open to SMEs, which is the same as the previous year.

The Ministry of Sustainability and Environment previously indicated that starting in 2024, government ICT contracts will include environmental sustainability criteria.

Suppliers who participate in the forthcoming PC and Printer bulk tender must follow energy and environmental regulations and reuse packaging and materials.

Additionally, GovTech is trying to optimise code reuse for cloud projects in FY 2023 and reduce the carbon footprint of the cloud infrastructure in GCC and government data centres to satisfy BCA-IMDA Green Mark criteria.

Singapore’s Niobium-Graphene Batteries Revolutionise Power Solutions

The Centre for Advanced 2D Materials (CA2DM) at the National University of Singapore (NUS), an innovator in the study of graphene and other 2-dimensional (2D) materials and the global leader in niobium products and technology, has created the first niobium-graphene batteries, which will solve all these problems.

Many modern gadgets, such as mobile phones, pacemakers, and electric vehicles, rely on batteries for electricity. Traditional lithium-ion batteries, on the other hand, have drawbacks such as safety issues, short life cycles, and lengthy charging periods.

Because traditional lithium-ion batteries have these limits, digital innovation has fuelled the development of novel battery technologies, such as niobium-graphene batteries, to overcome these concerns and revolutionise power solutions for modern gadgets.

The batteries are being evaluated at a new advanced battery laboratory that was recently created with a joint investment of USD 3.8 million (S$5 million) over three years, supported by the National Research Foundation of Singapore.

According to Professor Antonio Castro Neto, Director of CA2DM, the advanced battery laboratory is the most technologically advanced and well-equipped facility in Singapore for exploring new frontiers in battery technology.

The lab provides advanced equipment for researchers to generate new solid electrolytes, build diverse cell shapes, and ultimately put their inventions to the test. They have made great progress in developing niobium-graphene batteries, which are proving to be game changers in terms of safety, efficiency, and sustainability.

When compared to standard lithium-ion batteries, the pioneer niobium-graphene batteries have demonstrated superior performance and safety. Also, volatile, and flammable liquid electrolytes in lithium-ion batteries will be replaced by niobium-containing solid electrolytes, improving the safety and energy density of the innovative batteries.

Long life cycles, safety, fast charging, enhanced performance, and sustainability are all advantages of niobium-graphene batteries.

Niobium is the major active material in the negative electrode of batteries and is also used as an additive in the positive electrode. Graphene, on the other hand, is used to improve electronic conductivity and structural stability in both negative and positive electrodes.

The unique crystal structure of niobium materials in the negative electrode enables rapid charging without compromising the structure. Niobium materials in the positive electrode can increase ionic conductivity and protect the active material from degradation. In addition, the low density of graphene significantly enhances the electronic conductivity of both electrodes without diminishing the battery’s overall energy density.

In the first quarter of 2024, the final prototype of the niobium-graphene battery is anticipated to be completed.

As they have a longer lifespan than existing lithium-ion batteries, the new graphene-niobium batteries substantially reduce the total cost of ownership and have ultrafast charging capabilities. In addition, they offer a higher level of safety because even at high temperatures there is no danger of explosion.

In addition to being the first batteries to combine niobium applications on both the cathode and the anode, they also offer higher input and output power, a broader temperature operating range, and a higher state of charge. Thus, commercial and industrial applications, including regenerative braking systems for hybrid vehicles such as rails, trucks, and passenger cars; and heavy-duty applications, intralogistics, and cordless power tools, among others, can be developed for specific markets.

The new laboratory is outfitted with state-of-the-art facilities for advanced niobium-based batteries and solid electrolytes research and production.

The versatility of niobium-graphene batteries is a result of their high-performance capabilities. In the medical sector, they can power life-saving devices such as pacemakers and defibrillators, providing dependable and durable energy sources for life-saving procedures.

In the aerospace industry, batteries can be used in satellites and spacecraft to provide reliable and efficient power solutions for space missions. Niobium-graphene batteries are suitable for environments where dependability, longevity, and safety are of the utmost importance due to their durability and performance.

Breakthrough with AI Early Depression Screening System

Graduates of the Information Technology Programme at the Hong Kong Institute of Vocational Education (IVE) have created a system that uses artificial intelligence (AI) technology to evaluate emotional distress and depression levels, as well as associated risks, by analysing various factors such as the caller’s voice, emotions, and keywords.

Currently, various government departments and social welfare organisations offer mental health helplines and online support services. The “AI Early Depression Screening System” has been specifically developed for individuals seeking emotional assistance and the dedicated counselling volunteers who assist them.

For instance, within this system, counselling volunteers from the organisation can engage in online sessions with those seeking help through the platform. They can access the medical records and past conversation logs of the help-seekers.

OpenGov Asia — Photo The AI system that analyses voice emotions and keywords to assess emotional distress and depression levels<br >Image Credits VTC Press Release

As the online conversation begins, the system automatically analyses the caller’s speech tone, voice, and content to gain insights into their emotions. Additionally, the system provides a real-time transcription of the caller’s voice, enabling the identification of specific words used during the conversation.

To train the AI system and analyse the conversation content, the team used the depression research lexicon created by Stanford University, which consists of over 2,000 depression-related keywords. For instance, instances have been observed where single mothers repeatedly use the keyword “useless” to describe themselves. In such cases, the system records the frequency of usage and analyses its association with other words, allowing an estimation to be made that the help seeker may be experiencing emotional distress.

Once the conversation is concluded, the system performs an initial assessment of the social worker’s risk of depression or emotional distress. It displays keywords associated with depression and potential causes of the condition. Additionally, it automatically identifies words related to substance abuse, alcohol, gambling, and self-harm as part of assessing the potential suicidal tendencies of the help-seekers. In conclusion, the system offers mental health guidance and suicide prevention advice while generating reports for further analysis and follow-up by professionals.

A senior lecturer at the Department of Information Technology at IVE (Tsing Yi) and the project’s guiding authority, highlights the convenience and user-friendly nature of the integrated online consultation and intelligent analysis system. The system effectively presents counselling conversation data, aiding in preliminary screening and serving as a reference tool for professional counselling or medical staff. However, he emphasised that the diagnosis and treatment of mental health conditions still require the professional judgment of healthcare and counselling teams.

It is suggested that this system is suitable for mental health institutions, hospitals, clinics, and even insurance companies. The continuation of conversations regularly is encouraged to enable the system to gather more data, thereby improving the accuracy of its analysis. Currently, the system exclusively supports English, but the next objective is to optimise it to accommodate additional languages such as Cantonese and Mandarin.

The system has garnered significant recognition and achievements through participation in various competitions in China and Hong Kong.

IVE’s IT Discipline has developed a comprehensive range of programmes to equip learners with the necessary knowledge and skills to thrive in the fast-paced and ever-evolving career landscape. These programmes cover various domains within the field of Information and Communications Technology (ICT) as well as Multimedia and Entertainment Technology (MET). By offering a wide array of courses, the IT Discipline aims to ensure that learners stay up-to-date with the latest advancements and acquire the relevant expertise required in these dynamic industries.

AI-Discovery: Drug Targets Drug-Resistant Infections

Researchers at MIT McMaster University have identified a new antibiotic that can dispatch a type of bacteria responsible for many drug-resistant infections using an algorithm based on machine learning.

If the drug is formulated for patient usage, it could potentially aid in combating Acinetobacter baumannii, a bacterial species commonly present in healthcare facilities and associated with severe infections such as pneumonia, meningitis, and other critical ailments. Furthermore, this microorganism is a primary cause of infections among injured military personnel in Iraq and Afghanistan back then.

Jonathan Stokes, a former MIT postdoc who is now an Assistant Professor of Biochemistry and Biomedical Sciences at McMaster University, explained, “Acinetobacter has the ability to persist on hospital doorknobs and equipment for extended durations, and it can acquire antibiotic resistance genes from its surroundings. It is increasingly prevalent to encounter A. baumannii strains that resist nearly all available antibiotics.”

The scientists employed a machine-learning model to examine approximately 7,000 potential drug compounds and identify the new medication. The model was trained to assess whether a chemical compound could effectively hinder the growth of A. baumannii.

James Collins, the Termeer Professor of Medical Engineering and Science at MIT’s Institute for Medical Engineering and Science (IMES) and Department of Biological Engineering, said, “This discovery further reinforces the notion that AI has the potential to greatly accelerate and expand our quest for innovative antibiotics. I am thrilled that this research demonstrates the utility of AI in addressing challenging pathogens like A. baumannii.”

During the initial experiment, the researchers educated a machine-learning algorithm to recognise chemical compositions with the potential to impede the growth of E. coli. Employing this algorithm, they screened over 100 million compounds and discovered a molecule called halicin. Their investigations demonstrated that halicin could eliminate not only E. coli but various other bacterial strains that resist conventional treatment methods.

To gather training data for their computational model, the researchers initially exposed A. baumannii cultivated in a laboratory dish to approximately 7,500 distinct chemical compounds to identify those capable of impeding the microbe’s growth. Subsequently, they input the structure of each molecule into the model while providing information regarding whether each structure could inhibit bacterial growth. It enabled the algorithm to grasp the chemical characteristics associated with growth inhibition.

Once the model was trained, the researchers employed it to analyse a set of 6,680 compounds, which had not been previously encountered by the model. This analysis selected several hundred top candidate compounds within less than two hours. Among these candidates, the researchers handpicked 240 for experimental laboratory testing, focusing on compounds possessing distinct structures from existing antibiotics or molecules within the training data.

From the test’s results, the researchers discovered nine antibiotics, one of which exhibited exceptional potency. Interestingly, this particular compound, initially investigated as a potential treatment for diabetes, showcased remarkable efficacy in eliminating A. baumannii while having no impact on other bacterial species such as Pseudomonas aeruginosa, Staphylococcus aureus, and carbapenem-resistant Enterobacteriaceae.

The ability of this antibiotic to exhibit a narrow-spectrum killing effect is a highly desirable characteristic as it reduces the risk of bacteria swiftly developing resistance to the drug. Additionally, this attribute offers the advantage of potentially sparing beneficial bacteria in the human gut, which play a crucial role in suppressing opportunistic infections like Clostridium difficile.

Singapore-Kenya Boost Digital Economy, Sustainable Relations

During his first official visit to Kenya, Prime Minister Lee Hsien Loong thanked Kenyan President William Ruto for his gracious welcome. He noted that, despite their physical distance, Singapore and Kenya have similar perspectives.

“Our peoples share similar aspirations, such as inclusive growth, a high standard of living, ethnic and religious harmony, and good housing, healthcare and education,” said Prime Minister Lee.

Both countries have comparable perspectives on the difficulties the Global South faces. Inflation, pandemics, climate change, rising protectionism, rising geopolitical tensions, and dangers to the multilateral trading system are all issues that both are concerned about.

Both countries agreed that it was critical for nations to keep working to establish connections in the digital economy and to collaborate on issues related to food, energy, and sustainable development. In an increasingly connected world, making connections and partnerships in the digital economy gives people and companies the power to use technology, grow their reach, drive innovation, and achieve sustainable growth.

They reiterated Singapore’s and Kenya’s cordial and long-standing ties. They commemorated the 30th anniversary of their diplomatic ties two years ago. And in areas like governance, public service management, urban planning, and livable cities, the two nations collaborate and share experiences.

Both economic alliances have been expanding. In Sub-Saharan Africa, Kenya is one of Singapore’s key trading partners. Despite COVID-19, bilateral commerce grew by approximately 25% in 2021 compared to the previous year.

Several Singapore-based businesses are active in Kenya in several industries, including shipping, logistics and port management systems, agribusiness, tourism, and fintech solutions. Nairobi is host to a delegation of Singaporean businesses. They came to look for chances to partner with and invest in Kenyan businesses.

The two nations work effectively together in multilateral forums as well. They underlined their common support for multilateralism and a world order based on rules. Singapore and Kenya decided to keep working together at the UN and other multilateral institutions, as well as to work together to improve the UN’s effectiveness.

They also talked about potential new collaborations. In relation to ICT (information and communication technologies). A Memorandum of Understanding (MOU) has been struck in this regard, allowing the parties to share ICT best practices and information and foster innovation and talent development. The MOU would also promote and improve cybersecurity-related strategic cooperation.

In terms of climate change, they have inked an MOU in partnership with carbon credits under Article 6 of the Paris Agreement. This will stimulate, create, and facilitate mutually beneficial joint carbon credit ventures. International cooperation, such as this agreement between Singapore and Kenya, is important to boosting global climate action and achieving the Paris Agreement’s goals.

Both countries place a high value on talent development when it comes to human capital development. The MOU on Skills Development would promote deeper technical cooperation between the two countries in areas such as Leadership and Governance, Education, and Digitalisation. This will be accomplished through knowledge exchange, capacity-building courses, and other forms of collaboration.

There is a lot of room to enhance bilateral collaboration. Kenya’s strategic location acts as a gateway to East Africa for Singapore enterprises. Similarly, Singapore might act as a gateway to Southeast Asia for Kenyan businesses.

Both countries welcome the approval of the bilateral investment treaty and the President’s pledge to resolve the two countries’ Avoidance of Double Taxation Agreement as soon as possible. These initiatives send a strong, positive signal to businesses while also providing clarity and assurance on cross-border transactions and investment.

Singapore is eager to collaborate with President Ruto and his government to advance bilateral relations.

May 30, 2023

8th Annual Singapore OpenGov Leadership Forum 2023, 10 - 11 MAY 2023 - CLICK HERE FOR DETAILS

We are creating some awesome events for you. Kindly bear with us.

Tech v Human Touch in Patient Care

Singapore: Magnetic Muscle Therapy Reversing Ageing Trends

New Hi-Tech Lab Advanced Cellular Therapies Hong Kong

Fuelling Digital Growth: Singapore’s Continuing ICT Investments

Singapore’s Niobium-Graphene Batteries Revolutionise Power Solutions

Breakthrough with AI Early Depression Screening System

AI-Discovery: Drug Targets Drug-Resistant Infections

Singapore-Kenya Boost Digital Economy, Sustainable Relations

Recommended Stories

Singapore: Magnetic Muscle Therapy Reversing Ageing Trends

New Hi-Tech Lab Advanced Cellular Therapies Hong Kong

Fuelling Digital Growth: Singapore’s Continuing ICT Investments

Singapore’s Niobium-Graphene Batteries Revolutionise Power Solutions

Breakthrough with AI Early Depression Screening System

AI-Discovery: Drug Targets Drug-Resistant Infections

India’s Urban Future: Innovations in the Smart Cities Mission

New Hi-Tech Lab Advanced Cellular Therapies Hong Kong

AI to Accelerate Indonesia’s Banking System

The Philippines National Cybersecurity Plan Shaping a Secure Cyber Landscape

Reshaping Australia’s Energy Landscape with Portable Hydrogen Generators

New Zealand Balancing Productivity and Privacy in the Age of AI

Digital Tech Transforms Chengdu’s Cold Chain Logistics Sector

MENU

PARTNER

Qlik

PARTNER

CTC

PARTNER

Planview

SUPPORTING ORGANISATION

SIRIM

PARTNER

HashiCorp

PARTNER

IBM